Abstract 4140616: Proteomic biomarkers are associated with high-risk plaque phenotype and adverse events in the PROMISE trial
Year: 2024
Type: conference-abstract
Source: Circulation
Institutions: Duke University, Houston Methodist, Massachusetts General Hospital
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404363697
